Featured Research

from universities, journals, and other organizations

Newer type of radiation for prostate cancer recommended, experts say

Date:
October 27, 2010
Source:
Center for Advancing Health
Summary:
A review of existing research suggests that while a newer type of radiation for the treatment of prostate cancer does not help patients live longer compared to an older type -- at least when similar doses are given -- it does appear to reduce gastrointestinal side effects.

A new British review of existing research suggests that while a newer type of radiation for the treatment of prostate cancer does not help patients live longer compared to an older type -- at least when similar doses are given -- it does appear to reduce gastrointestinal side effects.

The newer type of radiation, known as intensity-modulated radiotherapy, has become common in the United States. However, it costs more than the older type − three-dimensional conformal radiotherapy − and the review authors could not determine if it's cost-effective.

The review is in the latest issue of Health Technology Assessment, the international journal series of the Health Technology Assessment program, part of the National Institute for Health Research in the United Kingdom.

There is no question that the new technology offers an improvement and fewer side effects; the question is how much health insurers will be willing to pay for it, said radiation oncologist Dr. Anthony D'Amico, who is not affiliated with the review but is familiar with its findings.

An estimated 217,730 men will develop prostate cancer in the United States this year and 32,050 will die from it, according to the National Cancer Institute. Several treatments exist, including removal of the walnut-sized prostate − a treatment that often causes impotence and incontinence − and radiation delivered from within the prostate through pellets or from outside the body.

The challenge of sending in radiation from the outside is that the prostate is close to the rectum and bladder, which can be hit by the radiation too, said D'Amico, chief of genitourinary radiation oncology at Brigham and Women's Hospital in Boston.

Three-dimensional conformal radiation was developed several decades ago. Guided by the results of scans, radiologists aim to hit the prostate with radiation from several directions instead of just from front to back as in the past, D'Amico said.

Intensity-modulated radiation therapy appeared in the 1990s, he said. It allows radiologists to adjust the intensity of radiation beam as it goes through parts of the prostate with different contours, reducing damage to other parts of the body − especially the rectum − that would also get hit by radiation.

In the new review, researchers looked at data from 13 studies mostly done in the United States -- eight full studies and five abstracts − comparing the two radiation approaches on 5,768 participants. None was a randomized controlled trial, considered the gold standard of medical research, in which researchers assign patients randomly to receive a certain treatment.

Why so few studies? "Lack of good quality research is not uncommon" when it comes to treatments that don't involve drugs, said lead review author Silvia Hummel, a senior analyst at the University of Sheffield in the United Kingdom. Drug studies must go through "well-defined steps, including a randomized trial, in order to be approved for use in patients, whereas other technologies often evolve and are not tested in the same way," she said.

Additionally, Hummel said, if clinicians believe that a new treatment is better, even if unproven, they might be reluctant to ask patients to participate in a trial.

Some studies looked at how long the patients survived after treatment and found no difference except in some cases when some patients lived longer after getting higher doses of intensity-modulated radiation therapy compared to those who got lower doses of three-dimensional conformal radiotherapy.

Most of the studies reported that patients who underwent intensity-modulated radiation therapy suffered from fewer gastrointestinal side effects such as rectal pain, bleeding and uncontrolled defecation. This appeared to be because the treatment does not cause radiation to hit as much of the rest of the body, especially the rectum.

A minority of the studies suggested that higher doses of intensity-modulated radiation therapy caused more side effects in the genitals and urinary system, such as incontinence and blood in the urine.

D'Amico, the U.S. radiation oncologist, said the review reflects the conclusions of not-yet-published research that supports intensity-modulated radiotherapy.

The British review did not come to any conclusions about whether the more-expensive therapy is cost-effective in terms of providing enough bang for the buck (or pound or euro).


Story Source:

The above story is based on materials provided by Center for Advancing Health. Note: Materials may be edited for content and length.


Journal Reference:

  1. Hummel, S. et al. Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation. Health Technol Assess, 2010; 14(47)

Cite This Page:

Center for Advancing Health. "Newer type of radiation for prostate cancer recommended, experts say." ScienceDaily. ScienceDaily, 27 October 2010. <www.sciencedaily.com/releases/2010/10/101027144941.htm>.
Center for Advancing Health. (2010, October 27). Newer type of radiation for prostate cancer recommended, experts say. ScienceDaily. Retrieved July 29, 2014 from www.sciencedaily.com/releases/2010/10/101027144941.htm
Center for Advancing Health. "Newer type of radiation for prostate cancer recommended, experts say." ScienceDaily. www.sciencedaily.com/releases/2010/10/101027144941.htm (accessed July 29, 2014).

Share This




More Health & Medicine News

Tuesday, July 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Deadly Ebola Virus Threatens West Africa

Deadly Ebola Virus Threatens West Africa

AP (July 28, 2014) West African nations and international health organizations are working to contain the largest Ebola outbreak in history. It's one of the deadliest diseases known to man, but the CDC says it's unlikely to spread in the U.S. (July 28) Video provided by AP
Powered by NewsLook.com
$15B Deal on Vets' Health Care Reached

$15B Deal on Vets' Health Care Reached

AP (July 28, 2014) A bipartisan deal to improve veterans health care would authorize at least $15 billion in emergency spending to fix a veterans program scandalized by long patient wait times and falsified records. (July 28) Video provided by AP
Powered by NewsLook.com
Two Americans Contract Ebola in Liberia

Two Americans Contract Ebola in Liberia

Reuters - US Online Video (July 28, 2014) Two American aid workers in Liberia test positive for Ebola while working to combat the deadliest outbreak of the virus ever. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Traditional African Dishes Teach Healthy Eating

Traditional African Dishes Teach Healthy Eating

AP (July 28, 2014) Classes are being offered nationwide to encourage African Americans to learn about cooking fresh foods based on traditional African cuisine. The program is trying to combat obesity, heart disease and other ailments often linked to diet. (July 28) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins